Viewing StudyNCT00276679



Ignite Creation Date: 2024-05-05 @ 4:37 PM
Last Modification Date: 2024-10-26 @ 9:22 AM
Study NCT ID: NCT00276679
Status: COMPLETED
Last Update Posted: 2013-09-17
First Post: 2006-01-12

Brief Title: Temozolomide in Treating Young Patients With High-Risk Relapsed or Refractory Neuroblastoma
Sponsor:
Organization: National Cancer Institute NCI